Royal Bank Of Canada Cuts UiPath (NYSE:PATH) Price Target to $15.00

UiPath (NYSE:PATH) had its price target cut by Royal Bank Of Canada from $17.00 to $15.00 in a report released on Wednesday,Benzinga reports. They currently have a sector perform rating on the stock.

A number of other equities research analysts also recently issued reports on the company. Oppenheimer reiterated a “market perform” rating on shares of UiPath in a research report on Friday, September 4th. Morgan Stanley reduced their target price on UiPath from $17.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday, May 29th. Needham & Company LLC restated a “buy” rating and issued a $22.00 target price on shares of UiPath in a research note on Wednesday. Weiss Ratings raised UiPath from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 9th. Finally, HC Wainwright reaffirmed a “buy” rating on shares of UiPath in a report on Friday, September 4th. Four equities research analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $16.06.

UiPath Trading Down 1.0%

UiPath stock opened at $12.47 on Wednesday. UiPath has a 1-year low of $9.20 and a 1-year high of $19.84. The firm has a market capitalization of $6.50 billion, a PE ratio of 18.62, a price-to-earnings-growth ratio of 1.18 and a beta of 1.02. The firm’s 50 day simple moving average is $14.53 and its 200 day simple moving average is $12.23.

UiPath (NYSE:PATH) last announced its quarterly earnings results on Thursday, September 3rd. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. The firm had revenue of $410.26 million during the quarter, compared to the consensus estimate of $397.77 million. UiPath had a net margin of 21.03% and a return on equity of 9.70%. The business’s quarterly revenue was up 13.3% compared to the same quarter last year. During the same period last year, the firm earned $0.15 EPS. Research analysts forecast that UiPath will post 0.49 earnings per share for the current year.

Insider Activity

In related news, COO Ashim Gupta sold 117,339 shares of the company’s stock in a transaction on Friday, September 11th. The shares were sold at an average price of $13.85, for a total value of $1,625,145.15. Following the completion of the transaction, the chief operating officer directly owned 2,037,377 shares in the company, valued at approximately $28,217,671.45. The trade was a 5.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Daniel Dines sold 1,402,347 shares of the stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $16.07, for a total value of $22,535,716.29. Following the completion of the transaction, the chief executive officer directly owned 26,491,238 shares in the company, valued at approximately $425,714,194.66. This represents a 5.03% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 1,560,150 shares of company stock worth $24,727,357. 22.44% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On UiPath

A number of hedge funds and other institutional investors have recently modified their holdings of PATH. Trifecta Capital Advisors LLC bought a new position in shares of UiPath during the 2nd quarter valued at about $27,000. AdvisorNet Financial Inc lifted its position in UiPath by 750.0% in the 1st quarter. AdvisorNet Financial Inc now owns 3,400 shares of the company’s stock worth $38,000 after buying an additional 3,000 shares during the last quarter. REAP Financial Group LLC bought a new stake in UiPath in the 4th quarter worth approximately $44,000. Global Retirement Partners LLC purchased a new stake in UiPath in the second quarter worth approximately $57,000. Finally, EverSource Wealth Advisors LLC boosted its stake in UiPath by 36.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 4,968 shares of the company’s stock worth $81,000 after buying an additional 1,329 shares in the last quarter. 62.50% of the stock is currently owned by hedge funds and other institutional investors.

UiPath News Roundup

Here are the key news stories impacting UiPath this week:

• Positive Sentiment: UiPath customer adoption is demonstrating real-world demand for agentic automation, with one customer reportedly processing approximately 100,000 medical billing cases per week. This supports the company’s case that its technology can deliver measurable productivity gains at enterprise scale. Accountable intelligence – how a UiPath customer is using agentic automation to process 100,000 medical billing cases a week
• Positive Sentiment: The company introduced Cartographer and additional workflow automation and software-testing capabilities intended to connect business processes, software agents and enterprise AI orchestration. These tools could expand UiPath’s addressable market if they accelerate customer adoption. UiPath’s new tool could unlock a much bigger wave of automated business processes
• Positive Sentiment: UiPath announced the 2026 GeekWire AI Breakthrough Award winners, showcasing enterprises using agentic AI in production. The recognition may improve market visibility and reinforce the company’s positioning in enterprise AI. UiPath Announces Winners of the 2026 Geekwire AI Breakthrough Awards
• Neutral Sentiment: Needham reaffirmed its Buy rating, while Barclays and TD Cowen maintained Hold ratings, indicating mixed Wall Street conviction rather than a clear consensus. Needham reaffirms Buy rating
• Negative Sentiment: BMO Capital Markets cut its price target from $18 to $15 and Canaccord Genuity reduced its target from $17 to $14; both firms now carry middle-ground ratings. UBS also lowered its target, adding to investor concerns about UiPath’s near-term upside. Why UiPath stock is down today
• Negative Sentiment: The stock’s decline was compounded by rising Treasury yields and a broader software-sector selloff. Although annual recurring revenue reached $1.938 billion, investors appeared focused on valuation pressure and the shares’ persistent monthly downtrend. UiPath stock falls as ARR reaches $1.938 billion

UiPath Company Profile

UiPath Inc (NYSE: PATH) develops enterprise automation software designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation (RPA), artificial intelligence, workflow orchestration and process intelligence to support automation across areas such as finance, customer service, human resources, information technology and operations.

The UiPath Platform includes tools for discovering and analyzing business processes, building and managing software robots, processing documents, testing applications and coordinating automated workflows.